Antiviral Drugs Market to Cross US$ 78 Bn in Revenues by the end of 2033 | According to Persistence Market Research New York, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Reverse Transcriptase Inhibitors to account for Over 50% of the Antiviral Drugs Sales in the Forthcoming Years, Forecasts Persistence Market Research ...

Antiviral Drugs Market revenue to cross USD 44.5 Bn by 2027: Global Market Insights Inc. Selbyville, Delaware, March 08, 2021 (GLOBE NEWSWIRE) -- According to latest report “Antiviral Drugs Market By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease...